Media Contacts

For more information contact our media team:

Stacy Sevcik
+1 314 529 3062
Send Email >

Next Event

  • e-Health Research International Congress 2016

    Paris, France
    Oct11 – 12, 2016

    Learn More

Kantar Health thought leaders are available to comment on a variety of healthcare- and pharma-industry-related topics. In addition, our proprietary data is available for media use, including patient population sizes, treatment rates and patient-reported behaviors and attitudes.

Welcome to the Kantar Health News Room RSS Feed News

Delivering the most current and unique insights on healthcare trends and news about Kantar Health.
  • Kantar Health, Sudler & Hennessey and All Global offer free webinar series on healthcare stakeholder trends in Europe

    Sep 13, 2012
    Kantar Health has partnered with Sudler & Hennessey and All Global to launch a new webinar series that will cover market access trends in key European countries from a stakeholder perspective, the implications of these trends, and how they relate to healthcare changes in other parts of the world.
    Continue Reading | Share
  • Kantar Health to Moderate Oncology Roundtable at PSA

    Sep 10, 2012
    Kantar Health today announced that Senior Vice President Ian Hicks will moderate an oncology roundtable at the Pharmaceutical Strategic Alliances Conference. The conference will take place September 17-19, 2012, at the Marriott Marquis in New York City.
    Continue Reading | Share
  • Comorbid Hypertension and Obesity among Patients with Type 2 Diabetes in Urban China Increases Healthcare Resource Use

    Sep 4, 2012
    Chinese patients with type 2 diabetes with comorbid hypertension or comorbid hypertension plus obesity see their physicians, visit the emergency room and are hospitalized significantly more often than type 2 diabetics without these comorbidities, according to new findings from Kantar Health presented today at the ISPOR 5th Asia-Pacific Conference.
    Continue Reading | Share
  • Neuropathic Pain Patients in Japan Have Worse Health Status Than Those with Other Types of Pain

    Sep 3, 2012
    Neuropathic pain is associated with significantly lower levels of health-related quality of life among Japanese patients compared with patients experiencing another type of pain and patients without pain, according to new findings from Kantar Health and presented today at the ISPOR 5th Asia-Pacific Conference.
    Continue Reading | Share
  • Kantar Health Promotes Jacombs to Managing Director, APMEA

    Sep 3, 2012
    Kantar Health has promoted Graeme Jacombs to Managing Director of the Asia Pacific, Middle East and Africa (APMEA) region.
    Continue Reading | Share
  • Kantar Health Hosting Oncology Conference Insight Seminars

    Aug 7, 2012
    Kantar Health will host Oncology Conference Insight seminars on September 18, 2012, in Madrid and September 20, 2012, in Milan. The seminars will highlight the implications of recent drug approvals and clinical results on the oncology competitive landscape and will offer an opportunity for a candid, mutual exchange of opinions and ideas.
    Continue Reading | Share
  • 71% of US Physicians Want Major Changes to Affordable Care Act

    Jul 10, 2012
    Nearly three in four US physicians feel Congress needs to enact major changes in the Affordable Care Act (ACA), according to research conducted by Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, in collaboration with Sermo, the leading physician online community in the US.
    Continue Reading | Share
  • Kantar Health to Present Recent Clinical Developments in Oncology

    Jul 9, 2012
    Kantar Health today announced that it will host a seminar highlighting the implications of recent drug approvals and clinical results on the oncology competitive landscape. The seminar is presented in conjunction with Synix Inc., Kantar Health’s partner in Japan.
    Continue Reading | Share
  • New Treatments in Melanoma May Steal Share from Yervoy

    Jun 27, 2012
    Physicians said they would use new treatments now in clinical trials in nearly 30% of their metastatic melanoma patients with BRAF mutations, mostly at the expense of Bristol-Myers Squibb’s Yervoy (ipilimumab), according to a survey conducted by Kantar Health.
    Continue Reading | Share
  • Physicians to Increase Zytiga Use in Chemo-Naive Prostate Cancer

    Jun 26, 2012
    Physicians said they would use Zytiga® (abiraterone acetate, Janssen) in more than half of their castrate-resistant prostate cancer (CRPC) patients who are asymptomatic or minimally symptomatic in the pre-chemotherapy setting, according to a survey conducted by Kantar Health.
    Continue Reading | Share
Page